Health Care & Life Sciences » Pharmaceuticals | Tianyin Pharmaceutical Co. Inc.

Tianyin Pharmaceutical Co. Inc. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
63,939.70
95,200.90
69,605.80
67,500.50
46,555.00
Cost of Goods Sold (COGS) incl. D&A
30,594.60
52,698.00
45,274.30
41,496.80
30,674.10
Gross Income
33,345.00
42,502.90
24,331.40
26,003.70
15,880.90
SG&A Expense
18,598.90
24,429.00
15,788.40
16,689.30
13,196.40
EBIT
14,746.10
18,073.90
8,543.00
9,314.40
2,684.50
Unusual Expense
-
1,627.60
-
-
-
Non Operating Income/Expense
39.50
-
189.30
-
3,070.80
Interest Expense
25.60
119.50
331.30
437.90
392.00
Pretax Income
14,681.00
19,714.70
8,610.00
9,039.10
612.70
Income Tax
2,626.10
4,091.90
2,368.10
2,423.90
195.30
Consolidated Net Income
12,054.80
15,622.80
6,241.90
6,615.20
808.10
Net Income
12,043.20
15,663.00
6,358.70
6,672.20
645.00
Net Income After Extraordinaries
12,043.20
15,663.00
6,358.70
6,672.20
645.00
Net Income Available to Common
11,553.50
15,520.00
6,358.70
6,672.20
645.00
EPS (Basic)
0.40
0.53
0.22
0.23
0.02
Basic Shares Outstanding
24,427.30
28,403.80
29,308.40
29,341.70
29,400.60
EPS (Diluted)
0.40
0.53
0.22
0.23
0.02
Diluted Shares Outstanding
30,081.70
29,743.20
29,308.40
29,341.70
29,400.60
EBITDA
15,699.90
19,261.60
9,758.20
11,749.60
5,272.10
Non-Operating Interest Income
-
132.80
209.00
162.60
165.50
Minority Interest Expense
11.70
40.20
116.80
57.00
163.10
Preferred Dividends
489.60
143.00
-
-
-

About Tianyin Pharmaceutical Co.

View Profile
Address
23/F, Unionsun Yangkuo Plaza
Chengdu Shanghai 610041
China
Employees -
Website -
Updated 07/08/2019
Tianyin Pharmaceutical Co., Inc. is engaged in the development, manufacturing, marketing and sale of modernized traditional Chinese medicines and other pharmaceuticals in China. Its products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology and pediatrics. The company was founded on August 20, 2002 and is headquartered in Chengdu, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.